The role of capsule aperture size on the dispersion of carrier-based formulation at different air flowrates

Int J Pharm. 2023 Jul 25:642:123152. doi: 10.1016/j.ijpharm.2023.123152. Epub 2023 Jun 18.

Abstract

The effect of capsule aperture size on the aerosol performance of lactose blend formulation was studied using Foradil® (containing 12 μg of formoterol fumarate (FF1) and 24 mg of lactose) dispersed with a powder inhaler Aerolizer® at increasing air flowrates. Apertures sizes of 0.4, 1.0, 1.5, 2.5, and 4.0 mm were introduced at the opposite ends of the capsule. The formulation was dispersed into a Next Generation Impactor (NGI) at 30, 60 and 90 L/min, with the fine particle fractions (FPFrec and FPFem) measured by chemical assay of FF and lactose using high-performance liquid chromatography. Particle size distribution (PSD) of FF particles dispersed in wet media was also characterized by laser diffraction. FPFrec showed a stronger dependency on the flowrate than the capsule aperture size. The most efficient dispersion was achieved at 90 L/min. At a given flowrate, FPFem remained broadly constant across different aperture sizes. The laser diffraction studies demonstrated the presence of large agglomerates.

Keywords: Aerosol; Capsule aperture; Carrier-based formulation; Dry powder inhaler; Foradil; Powder.

MeSH terms

  • Administration, Inhalation
  • Aerosols / chemistry
  • Dry Powder Inhalers
  • Formoterol Fumarate
  • Lactose* / chemistry
  • Nebulizers and Vaporizers*
  • Particle Size
  • Powders

Substances

  • Lactose
  • Aerosols
  • Formoterol Fumarate
  • Powders